Comment from Anonymous

Dear Commissioner Makary, As an internal medicine doctor practicing in Michigan, I would like to oppose ACOG's recent petition to remove Mifepristone from the REMS. The recent comments from FRC summarizes the situation well "On April 28, 2025, not long after ACOG submitted its petition, the Ethics and Public Policy Center (EPPC) released new data on 865,727 prescribed mifepristone abortions that occurred between 2017 and 2023. The findings revealed that 10.93 percent of women experienced sepsis, infection, hemorrhaging, a trip to the emergency room, a follow-up surgical abortion, or another serious event within 45 days of a prescribed mifepristone abortion. Notably, although the general public regards each of these complications as serious, not all of them are classified as “serious adverse events” by the FDA." This drug is fatal to babies in the womb and brings real risk of bodily harm to expecting mothers, as the above study evidences. Instead of relaxing restrictions on use of this dangerous drug, the previous safety requirements such as in person prescribing by a physician only, a pelvic ultrasound to rule ectopic pregnancies, a blood test to rule Rh negative status should be required at a minimum. This drug is currently being abused in violation of the Comstock Act, which states that materials used for abortion may not be sent through the mail. Thank-you for considering these comments.